Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
(2R,3S)-Azelaprag
Cat. No.:
OB0425LY-243
Appearance:
Solid
Purity:
99.02%
Identity:
Confirmed by NMR, HPLC, and MS.
Size:
Add to basket
Product Overview
Description:
(2R,3S)-Azelaprag is a potent Apelin receptor agonist. Its molecular conformation optimizes the biological activity.
Synonyms:
(2R,3S)-N-(4-(2,6-Dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-4H-1,2,4-triazol-3-yl)-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide; (2R,3S)-N-[4-(2,6-Dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide; 2049979-31-7; (2R,3S)-AMG 986
CAS No.:
2049979-31-7
Compound CID:
122701379
Formula:
C25H29N7O4S
Formula Weight:
523.61
Specification
Target:
Apelin receptor (APJ); Drug isomer
Pathway:
GPCR/G protein; Others
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
(2R,3S)-Azelaprag shows promise in studies on the regulation of blood glucose and lipid metabolism.
